Did National Vision beat or miss consensus estimates last quarter?

What is National Vision's gross profit margin?

What does National Vision do and what are its main business segments?

What is the revenue and EPS growth rate for National Vision year over year?

What were the key takeaways from National Vision’s earnings call?

What is the market's earnings forecast for National Vision next quarter?

What were the key takeaways from National Vision's earnings call?

What guidance did National Vision's management provide for the next earnings period?

- **Revenue Growth**: 7.7% adjusted comparable store sales growth, driven by premium frames and strategic pricing. 2026 guidance assumes similar ticket growth from pricing, assortment, and customer mix shifts.
- **AI and Tech Innovation**: Meta-enabled smart glasses rolling out to 250 stores by Q4; digital selling tools for associates to be live in all stores by year-end.
- **Financial Performance**: Non-GAAP EPS of $1.08, operating margin expansion of 120 basis points year-to-date. 2025 outlook includes $1.97-1.99B revenue and 5-6% comp store sales growth.
- **Customer Segmentation**: Managed care and progressive lens customers driving low-teens comp growth. Cash pay customers opting for premium products at higher rates than expected.
- **Risk Management**: Health care costs remain a headwind, but disciplined expense control and variable incentive programs are mitigating impact.

**【CEO Summary Section】**
- **Revenue Growth**: Adjusted comparable store sales grew 7.7% year-over-year, driven by a 90 basis point expansion in operating margin. Key contributors include higher average ticket from premium frames (e.g., Jimmy Choo, Hugo Boss) and strategic pricing actions on lenses and add-ons.
- **AI and Technology Integration**: Rolled out Meta-enabled smart glasses in 50 stores, with plans to expand to 250 locations by Q4. Digital selling tools for associates are being implemented in all stores by year-end.
- **Customer Segmentation**: Managed care, progressive lens, and outside Rx customers drove low-teens comp sales growth. Cash pay customers are increasingly opting for premium products, with frame sell-through exceeding expectations.
- **Pricing Strategy**: Q4 pricing actions include modernizing lens packages (e.g., $95 exam price) and phasing out decimal points to align with consumer feedback. 2026 guidance assumes similar ticket growth contributions from pricing, assortment, and customer mix shifts.

**【CFO Financial Commentary】**
- **Financial Highlights**: GAAP net income of $420 million, Non-GAAP EPS of $1.08 (vs. $0.95 prior year). Adjusted operating margin expanded 120 basis points year-to-date to 4.1%.
- **Cost Management**: SG&A leverage of 10 basis points despite $80-85 million in CapEx for new stores and IT investments. Health care costs remain a headwind, offset by disciplined expense control and variable incentive programs tied to performance.
- **2025 Outlook**: Revenue $1.97-1.99B, adjusted EPS $0.63-0.71, and 5-6% comp store sales growth. Gross margin expected to expand slightly, supported by pricing actions and assortment modernization.

**【Q&A Highlights】**
- **Pricing and Competition**: CEO emphasizes surgical lens pricing evolution (e.g., coatings, materials) to balance consumer value with category trends. National Vision is gaining share in both unit and dollar basis, outpacing industry exam growth rates.
- **Cash Pay Consumer Behavior**: Despite depressed purchase cycles, cash pay customers are trading up to premium frames and lenses at higher rates than expected, contributing to ticket growth.
- **Remote Exam Penetration**: Over 70% of stores enabled with remote capabilities, with state-by-state regulatory constraints limiting further expansion.
- **2026 Strategy**: Focus on modernizing CRM platforms, evolving pricing architecture (e.g., $95 exam price), and scaling smart glasses technology. Eyeglass World brand is seeing mid-single-digit comps, borrowing from America's Best playbook.

National Vision Holdings, Inc. (EYE) Q3 2025 Earnings Call Transcript

- **Revenue Beat**: 7.7% revenue growth, 5.9% comp store sales growth, 69% adjusted operating income growth.
- **Managed Care Momentum**: Low double-digit comp growth, targeting 50% managed care mix.
- **Margin Expansion**: 2025 adjusted EPS guidance raised to $0.62-$0.70, gross margin expected to expand.
- **Strategic Investments**: New branding, CRM platform, designer frames, and remote exams driving customer engagement.
- **Cost Control**: $12 million expense savings, 1.3x net debt/EBITDA, no material tariff impact.

**【CEO Summary Section】**
- **Revenue Growth**: Q2 2025 revenue grew 7.7%, driven by 5.9% adjusted comp store sales growth, with 69% year-over-year growth in adjusted operating income. Managed care comp sales grew in the low double digits, while cash pay comp sales grew in the low single digits.
- **Strategic Initiatives**: Launched new branding for National Vision and America's Best ("Every Eye Deserves Better"), expanded CRM capabilities with Adobe, and introduced designer frame partnerships (Jimmy Choo, Hugo Boss). Remote exam technology surpassed 1 million exams.
- **Customer Experience**: Conducted lifestyle training for associates, focusing on premium product assortment (40% of frames priced over $99) and personalized selling. Net Promoter Scores increased.
- **Market Expansion**: Targeting higher-income brackets ($75k-$100k) and non-managed care customers with premium lenses and frames. Eyeglass World (EGW) saw best first-half performance since 2021 after leadership changes.

**【CFO Financial Commentary】**
- **Financial Highlights**: Q2 2025 adjusted EPS of $0.18 (vs. $0.15 in 2024), gross margin expanded due to price increases and cost leverage. Full-year guidance raised to $1.93-$1.97 billion in revenue, $0.62-$0.70 in adjusted EPS.
- **Cost Management**: $12 million in expense savings from prior actions, offset by higher variable compensation and healthcare costs. Gross margin expected to expand slightly for 2025.
- **Balance Sheet**: $48 million cash balance, $327 million total liquidity. Settled $84.8 million convertible notes, reducing net debt to $272 million (1.3x net debt/EBITDA).
- **Tariff Mitigation**: Latest tariffs reduced expected impact, with no additional pricing actions assumed in guidance.

**【Q&A Key Highlights】**
- **Managed Care Growth**: Low double-digit comp growth driven by ticket and traffic, targeting 50% managed care mix. New CRM platform and branding expected to enhance retention.
- **Cash Pay Strategy**: Shifting focus from promotions to premium products, with cash pay consumers trading up to higher-priced frames. 2% annual shift from cash pay to managed care observed.
- **Margin Outlook**: Long-term margin expansion focus, with 200+ basis points of runway from cost optimization and assortment changes. 2025 operating margin expected to improve from 4.5%-5% to historical 6.5%-7% range over time.
- **Store Rationalization**: 20 closures planned for 2025, focusing on profitability and demographic alignment. Remote exams and employed doctor models improving EGW performance.
- **Tariff Impact**: Mitigation strategies reduced 2025 tariff impact to negligible, with no material P&L effect.


National Vision (EYE)-6 Aug 25-2025 Q2 Earnings call transcript

- **Revenue Growth**: Q1 2025 revenue up 5.7% to $510M, with 5.5% adjusted comps driven by high-value customer segments.
- **Strategic Momentum**: Double-digit comps from managed care, progressive, and outside Rx customers, supported by pricing (+4.5% ticket) and new product launches.
- **Tariff Mitigation**: $10M-$15M incremental costs expected, to be offset by pricing and cost savings, with FY25 guidance raised.
- **Leadership Transition**: Smooth handover to Alex Wilkes as CEO, with Reade Fahs transitioning to Executive Chair.
- **Operational Efficiency**: 21.8% increase in adjusted operating income to $41.3M, driven by gross margin expansion and SG&A leverage.


**【CEO Opening Remarks】**
- Q1 2025 revenue rose 5.7% to $510 million, with adjusted comparable store sales up 5.5%, marking the 9th consecutive quarter of positive growth.
- Key growth drivers: double-digit comps from managed care, progressive, and outside Rx customers, supported by pricing actions and product assortment changes.
- Transition to Executive Chair effective August 1, with Alex Wilkes succeeding as CEO, ensuring smooth leadership continuity.

**【Alex Wilkes (Incoming CEO) Strategy Update】**
- National Vision's unique value proposition: industry-leading optometry network + scale as a value provider.
- Strategic focus: segmentation (targeting high-value customers), personalization (enhanced selling techniques), and digitization (CRM, digital tools).
- Pricing actions (+4.5% average ticket) and product launches (e.g., Lam & 10 Baker frames) driving revenue growth without degradation in conversion rates.
- Cost control initiatives: $12M in corporate expense reductions, with further savings in pipeline.

**【CFO Chris Laden Financial Highlights】**
- Q1 2025 adjusted operating income up 21.8% to $41.3M, driven by gross margin expansion (40.2% vs. 39.7% prior year) and SG&A efficiency.
- Tariff mitigation: $10M-$15M incremental product costs expected for FY25, to be offset by pricing actions and cost savings.
- FY25 guidance updated: adjusted comparable store sales 1.5%-3.5%, adjusted EPS $0.59-$0.67, reflecting stronger-than-expected Q1 performance.

**【Q&A Key Takeaways】**
- **Tariff Impact**: Company confident in ability to neutralize tariff effects through pricing and cost reduction, with $10M-$15M incremental costs for FY25.
- **Customer Segmentation**: Higher-income customers driving traffic growth, while lower-income cash payers face macroeconomic headwinds.
- **Remote Exams**: Now routine part of operations, with minimal impact on profitability as exam coverage stabilizes.
- **Advertising Strategy**: Shifting to more efficient media mix and CRM-driven campaigns, with no immediate plans for ad spend reduction.


National Vision (EYE)-7 May 25-2025 Q1 Earnings call transcript

- **Revenue Growth & Profitability**: 2024 revenue up 3.8% to $1.823B, adjusted EBITDA +21.5% to $65.5M, driven by managed care (40% of sales).\n- **Strategic Shift**: 2025 focus on higher-value customers with pricing adjustments (+$10 two-pair offer), new products (Nuance audio glasses), and digital transformation (Adobe CRM).\n- **Operational Efficiency**: 10% SG&A reduction target, 43 store closures by 2026, and smaller-format store pilot.\n- **Leadership Transition**: Chris Laden to join as CFO on March 31, supported by interim CFO Patrick Moore.\n- **2025 Outlook**: Revenue growth 3-5%, adjusted EBITDA $65-70M, with cautious guidance amid macro uncertainty.

**【CEO Opening Remarks】**
- **2024 Financial Highlights**: Revenue grew 3.8% to $1.823B, with adjusted comparable store sales up 1.3%. Adjusted EBITDA increased 21.5% to $65.5M, driven by strong managed care sales (40% of revenue).\n- **Strategic Transformation Progress**: Expanded remote exam capabilities to 730+ locations, with remote exams accounting for 12% of total exams. Introduced hybrid remote pilot, enabling in-store doctors to serve other locations.\n- **Leadership Transition**: Melissa Rasmussen stepping down as CFO; Chris Laden to join as new CFO on March 31, supported by interim CFO Patrick Moore.\n- **2025 Outlook**: January sales strong, but February saw traffic decline amid colder weather and economic uncertainty. Guidance range widened to reflect macro risks.\n
**【President Alex Wilkes: 2025 Strategic Priorities】**
- **Customer-Centric Pricing**: Shift from cash-pay focus to managed care (40% growth). Implemented $10 increase in two-pair offer for both America's Best and Eyeglass World.\n- **Enhanced Customer Experience**: New product launches (Nuance audio glasses, Ray-Ban Meta) targeting higher-income segments. BioAge pilot expanded to 117 stores.\n- **Digital Transformation**: Adobe CRM and e-commerce platform upgrades. Partnered with VML for modernized digital marketing.\n- **Operational Efficiency**: Store fleet optimization (43 store closures by 2026) and smaller-format pilot for America's Best.\n
**【CFO Melissa Rasmussen: Financial Review】**
- **Q4 2024 Results**: Revenue $437.3M (+3.9%), adjusted EBITDA $3.2M. Full-year adjusted EPS $0.52, beating expectations.\n- **2025 Guidance**: Revenue growth 3-5%, adjusted EBITDA $65-70M. Focus on SG&A reduction (10% target) and reinvesting savings into customer experience.\n
**【Q&A Highlights】**
- **Managed Care Growth**: 2024 comped high single digits; 2025 targeting mid-single digit growth.\n- **Store Optimization**: Smaller-format stores to test in 2025, focusing on urban and college markets.\n- **Digital Investment**: $10M+ annually in CRM and e-commerce, aiming for 5%+ online sales contribution.\n- **Competition Strategy**: Differentiate via eye care expertise and omnichannel experience.\n- **CFO Transition**: Patrick Moore to ensure smooth handover, with Chris Laden expected to deliver long-term value.

EYE

EYE fundamentals

Earnings Call

You can ask Aime